中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
10期
126-127,128
,共3页
埃索美拉唑%奥美拉唑%泮托拉唑%消化道溃疡%成本-效果分析
埃索美拉唑%奧美拉唑%泮託拉唑%消化道潰瘍%成本-效果分析
애색미랍서%오미랍서%반탁랍서%소화도궤양%성본-효과분석
Esomeprazole%Omeprazole%Pantoprazole%Peptic uler%Cost-effectiveness
目的:评价埃索美拉唑、奥美拉唑与泮托拉唑3种三联方案治疗消化道溃疡的成本-效果。方法:选取本院2013年1-7月收治的114例消化性溃疡患者,按照随机数字表法将其分为A、B、C组各38例,A组给予埃索美拉唑肠溶片+克拉霉素片+阿莫西林片,B组给予奥美拉唑肠溶片+克拉霉素片+阿莫西林片,C组给予泮托拉唑肠溶胶囊+克拉霉素片+阿莫西林片,运用药物经济学成本-效果分析法对3种方案进行分析。结果:3组的治疗效果中,A组总有效率94.7%最高,其次为C组89.5%,B组86.8%最低,但组间比较差异均无统计学意义(P>0.05);3组成本-效果比分别为9.83、3.97、5.42。结论:3种治疗方案中,奥美拉唑联合两种抗菌药物治疗消化道溃疡的方案较优,且安全性较高,值得在临床上推广。
目的:評價埃索美拉唑、奧美拉唑與泮託拉唑3種三聯方案治療消化道潰瘍的成本-效果。方法:選取本院2013年1-7月收治的114例消化性潰瘍患者,按照隨機數字錶法將其分為A、B、C組各38例,A組給予埃索美拉唑腸溶片+剋拉黴素片+阿莫西林片,B組給予奧美拉唑腸溶片+剋拉黴素片+阿莫西林片,C組給予泮託拉唑腸溶膠囊+剋拉黴素片+阿莫西林片,運用藥物經濟學成本-效果分析法對3種方案進行分析。結果:3組的治療效果中,A組總有效率94.7%最高,其次為C組89.5%,B組86.8%最低,但組間比較差異均無統計學意義(P>0.05);3組成本-效果比分彆為9.83、3.97、5.42。結論:3種治療方案中,奧美拉唑聯閤兩種抗菌藥物治療消化道潰瘍的方案較優,且安全性較高,值得在臨床上推廣。
목적:평개애색미랍서、오미랍서여반탁랍서3충삼련방안치료소화도궤양적성본-효과。방법:선취본원2013년1-7월수치적114례소화성궤양환자,안조수궤수자표법장기분위A、B、C조각38례,A조급여애색미랍서장용편+극랍매소편+아막서림편,B조급여오미랍서장용편+극랍매소편+아막서림편,C조급여반탁랍서장용효낭+극랍매소편+아막서림편,운용약물경제학성본-효과분석법대3충방안진행분석。결과:3조적치료효과중,A조총유효솔94.7%최고,기차위C조89.5%,B조86.8%최저,단조간비교차이균무통계학의의(P>0.05);3조성본-효과비분별위9.83、3.97、5.42。결론:3충치료방안중,오미랍서연합량충항균약물치료소화도궤양적방안교우,차안전성교고,치득재림상상추엄。
Objective:To evaluate the cost-effectiveness of esomeprazole,omeprazole and pantoprazole three therapeutic regimens in the treatment of peptic uler.Method:A total of 114 patients with peptic ulcer were selected in our hospital from January 2013 to July 2013,they were randomly divided into group A,group B and group C,38 cases in each group.The group A was treated with esomeprazole+clarithromycin+amoxicillin,the group B was treated with omeprazole+amoxicillin+clarithromycin,the group C was treated with pantoprazole+clarithromycin+amoxicillin.Three therapeutic schemes were analyzed by using pharmacoeconomic cost-effectiveness analysis.Result:The treatment effect of the 3 groups, the total efficiency of group A was 94.7%,it was the highest,followed by group C was 89.5%,group B was 86.8%,it was the lowest,but there was no significant difference in the three groups(P>0.05),ratio of cost-effectiveness was 9.83,3.97, 5.42.Conclusion:In 3 types of treatment,omeprazole combined with two kinds of antibacterial drugs in the treatment of peptic ulcer is better,and the safety is high,it is worth promoting in clinical practice.